Dermisonics Inc. - DMSI

Dermisonics Inc. (DMSI)
http://www.dermisonics.com/
Coverage: November 12, 2005 - May 12, 2006
Featured: November 12, 2005

Latest Newsletter Editions

spacer
Sun, Feb 19, 2006 @ 09:02 am
Interest Rates and Oil: A FED Led Market Doldrum 2006 kicked off with a Bang. On January 3rd, someone flipped the micro cap stock switch, and we enjoyed a couple of breakouts early in the year. The second half of 2005 was brutal, so I guess we were entitled to a rebound. It's the first time in many...
Tue, Dec 20, 2005 @ 01:12 pm
Comments in the BLOG No new comments in the BLOG. To use the BLOG, simply go to the home page at www.otcjournal.com - the BLOG will scroll down automatically on the right side of your screen. The most current journal entries appear in the middle of your screen. Check back frequently for updates particularly...
Mon, Dec 12, 2005 @ 01:12 pm
Comments in the BLOG The most recent BLOG postings are on Callisto Pharmaceuticals (AMEX: KAL), and HyperDynamics (AMEX: HDY). I published a "profit alert" on KAL when it was over $1.50- a profit alert means traders should look at taking partial or all their profits. Long term investors need not act...
Sat, Nov 12, 2005 @ 08:11 am
Comments in the BLOG I'm planning a BLOG posting on the move up in HESG based on yesterday's QVC announcement. I'll get to it over the weekend. If you want a technical comment on the way the stock is behaving, you will find it by Monday morning. I am choosing to wait until the market closes today so...

spacer

Latest Blog Entries

spacer

Quote Data

spacer
Last Trade: Bid: 0.0000
Last Size: 0 Ask: 0.0000
Trade Time: Bid x Ask Size:
Change: +0.0000 (+0.00%) Day's Range: 0.00 - 0.00
Prev Close: 0.0000 52wk Range: 0.00 - 0.00
Open: 0.0000 P/E (ttm):
Volume: 0 EPS (ttm):
spacer [Chart]

Business Summary

spacer
Dermisonics, Inc., a development stage company, engages in the development of ultrasonic transdermal drug-delivery technologies. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. This system is based on a radical integration of microelectronics and ultrasonic science with a product-carrying patch. Dermisonics also developed other portable ultrasonic systems, including the U-Wand and A-Wand systems for applications in the skin care and medical fields, respectively. The A-Wand is a hand held, portable, ultrasonic wand device for applying antiseptic solutions to cuts, abrasions, and wounds with a replaceable Patch-Cap, which holds up to 40 ml of antiseptic cream. The U-Wand is an ultrasonic cosmetic applicator device that is used to apply skin care compounds topically to the surface of the skin. The company was founded in 2000 and was formerly known as Second Stage Ventures, Inc. It changed its name to Dermisonics, Inc. in 2004. Dermisonics is based in Irvine, California.

Disclosure

spacer
MarketByte LLC has been paid a fee of $30,000 by Dermisonics for coverage of the company. In addition, Trilogy Capital Partners has assigned MarketByte LLC 285,000 warrants, convertible currently into restricted shares, at an exercise price of $.72, for coverage of Dermisonics.

Recent News Headlines

spacer
Yahoo! Finance: RSS feed not found
RSS feed not found. Please remove this RSS feed or check Yahoo! Finance for more symbols.